Reuters Pharma USA 2023 - Day 1

Market Access
Reuters Pharma USA 2023 - Day 1

Reuters Pharma USA 2023 - Day 1

Thanks for joining us here in the City of Brotherly Love for the start of this year's Reuters Pharma USA conference. Day 1 begins with a single main stage track in the morning, where we’ll hear from Genentech CEO Alexander Hardy about reinventing pharma’s role in healthcare and from Takeda's US head, Julie Kim, about digital transformation in healthcare and its effect on health equity.

Then, in an afternoon of breakouts, we’ll hear about cell and gene therapy and challenges to its business models, using data to adapt your business, and how pharma marketers can use AI. We’ll also hear from our first pair of patient advocates in a session with Genentech. Check it all out below as the day goes on.